Post by
Gbathat on May 19, 2021 9:35pm
Why April 1st?
I'm still stuck on the April 1st date for accreditation of serology assay. It is too coincidental that it just happened to fall one day after the reporting period. Question is, why would they not want to disclose this awesome development?
Choose the best answer
a. They hate us, Elliot is just rolling in our dollars, and it's all a big lie (farmerjane's answer)
b. Licensing discussions with big pharma partner and a desire to not front run associated PRs by big pharma
c. BCNI just wants to have everything all set before the PRs so they don't get overwhelmed with test kit enquiries prior to having scaled up manufacturing/distribution?
d. other, ___________
My hope is it's B. C would be okay too.
Comment by
Thenorth1990 on May 20, 2021 4:19am
we will take a back up for June 4 in case Aducanumab gets rejected , for which the probability is really high . So there is a a good chance we drop another 60% and then they might announce . It will awesome if biogen is given a green light
Comment by
DavidKingCanada on May 20, 2021 10:52am
The only reason PMN.to is staying above 0.17 is because of the new Investors and Board of Directors. Even if Aducanumab is rejected, I don't see the price dropping 60%. If it does, I'm buying all the Stocks available!